The Ozempic Effect on Food Business: How Snack Brands Are Pivoting

Weight-loss medications like Ozempic and Wegovy are changing how Americans eat. With millions of people experiencing drastically reduced appetites, major food manufacturers are realizing they need a new game plan. Snack brands are now rethinking portion sizes, ingredients, and marketing to keep up with this massive shift in consumer behavior.

The Data Behind the Diet Shift

The rise of GLP-1 medications (the class of drugs that includes Ozempic, Wegovy, Mounjaro, and Zepbound) is not just a temporary health trend. It is a measurable economic shift.

Morgan Stanley estimates that up to 30 million Americans could be taking GLP-1 medications by 2030. Research shows that patients on these drugs consume roughly 20 percent to 30 percent fewer calories on a daily basis. They also tend to reduce their intake of high-sugar and high-fat foods.

Retailers are already seeing the impact at the checkout counter. Walmart US CEO John Furner noted late last year that the company was seeing a slight pullback in overall basket size for customers known to be taking these medications. Shoppers on GLP-1 drugs were buying slightly less food overall and steering clear of highly caloric items. This data served as a massive wake-up call to the global food industry.

Nestle Leads the Charge with Targeted Meals

Nestle, the largest food company in the world, is taking direct action to capture this new demographic. In May 2024, the company announced a brand new line of frozen foods called Vital Pursuit.

This product line is specifically designed and marketed for people taking GLP-1 weight-loss drugs. Nestle recognized that people on these medications have very specific dietary needs. Because patients eat far less, the food they do consume needs to pack a heavy nutritional punch to prevent malnutrition and muscle loss.

The Vital Pursuit line includes frozen bowls, sandwich melts, and pizzas. Every item is formulated to be high in protein, rich in fiber, and fortified with essential nutrients like calcium and iron. Furthermore, the portion sizes are strictly controlled to accommodate shrinking appetites. Nestle plans to price these items around $4.99 or less, making them highly accessible for everyday shoppers.

Snack Giants Rethink Portion Sizes

People taking appetite-suppressing drugs do not completely stop eating snacks. However, their physical capacity to finish a standard bag of chips or sleeve of cookies is significantly reduced. This reality is forcing snack giants to pivot their packaging strategies.

Mondelez International is the powerhouse behind iconic brands like Oreo cookies and Ritz crackers. CEO Dirk Van de Put has publicly discussed how the company is studying the GLP-1 trend. Mondelez is leaning heavily into portion-controlled packaging. Instead of family-sized bags, the company is focusing on snacks that come in smaller, 100-calorie packs or bite-sized formats. This allows consumers to satisfy a craving without feeling overwhelmed by a large portion.

Kellanova, the maker of Pringles, Cheez-It, and Pop-Tarts, is adopting a similar strategy. The company is actively monitoring consumer habits and emphasizing its single-serve bags. By offering smaller physical packages, these companies can keep GLP-1 users buying their products without contributing to food waste.

The Massive Push for Protein

One of the major side effects of rapid weight loss is the loss of lean muscle mass. Doctors highly recommend that patients on Ozempic or Wegovy consume elevated levels of protein to counteract this issue. Food businesses are capitalizing heavily on this medical advice.

Conagra Brands, the parent company of Healthy Choice and Slim Jim, sees the GLP-1 boom as a massive opportunity for its meat-based snacks. CEO Sean Connolly has highlighted that high-protein meat snacks like Slim Jim are perfectly positioned for consumers who need dense, quick protein without eating a heavy meal. Conagra is also evaluating its frozen food lines to ensure they meet the protein requirements of modern dieters.

Beverage companies are also seeing a boost in this category. Danone, known for its yogurt brands like Oikos, is seeing increased demand for its high-protein dairy products. Coca-Cola’s Fairlife milk brand, which filters out lactose and leaves behind a much higher protein content than standard milk, has also seen explosive growth as dieters look for easy ways to drink their daily protein requirements.

Rethinking the Grocery Aisle

The impact of weight-loss drugs goes beyond the specific products themselves. It is changing how grocery stores will look in the future.

As food companies introduce more protein-heavy, portion-controlled items, supermarket buyers have to make space on the shelves. We are likely to see a reduction in the shelf space dedicated to bulk-sized sugary snacks. In their place, retailers will stock more nutritional shakes, high-fiber frozen meals, and protein-fortified snacks.

Food brands that fail to adapt to this shift risk losing millions of customers over the next decade. The companies that thrive will be the ones that view GLP-1 users not as lost customers, but as a brand new market with highly specific nutritional demands.

Frequently Asked Questions

What are GLP-1 medications? GLP-1 medications are a class of drugs originally developed for type 2 diabetes that are now widely used for weight loss. Popular brand names include Ozempic, Wegovy, Mounjaro, and Zepbound. They work by mimicking a hormone that targets areas of the brain that regulate appetite and food intake.

How much less do people eat on Ozempic? Studies and surveys show that people taking GLP-1 weight-loss drugs typically consume roughly 20 percent to 30 percent fewer calories per day. They also tend to crave fewer sugary and high-fat foods.

What is Nestle’s Vital Pursuit? Vital Pursuit is a new line of frozen foods created by Nestle specifically for users of GLP-1 weight-loss medications. The meals focus on high protein, added fiber, and smaller portion sizes to help users get the nutrients they need while eating less volume.

Why are food companies making smaller packages? Because weight-loss drugs significantly reduce a person’s appetite, consumers are unable to finish large, traditional portions of snacks. Companies like Mondelez and Kellanova are increasing their focus on smaller, single-serve, or bite-sized packages to accommodate these smaller appetites and reduce food waste.